The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity

ABSTRACT: T-cell activation is essential for effective immune responses, yet its precise regulatory mechanisms remain incompletely understood. In this study, we show that the deubiquitinases of the Ubiquitin-Specific Peptidase 17-like (USP17L) family are significantly upregulated following T-cell stimulation. Using CRISPR-mediated gene knockout mice, we demonstrate that USP17LA, but not USP17LB, acts as a negative regulator of T-cell activation. Loss of Usp17la leads to increased production of pro-inflammatory cytokines, enhanced T-cell proliferation and effector functions, without affecting T-cell development or homeostasis. Furthermore, Usp17la deletion augments TCR signaling and anti-tumor immunity, improving T-cell−mediated tumor surveillance in murine tumor models. Mechanistically, proteomic an

SUBMITTER: Huiling Zhang 

PROVIDER: S-SCDT-10_1038-S44319-025-00584-5 | biostudies-other |

REPOSITORIES: biostudies-other